Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy Gibson, C. M., Arbetter, D. F., Jain, P., Halaby, R., Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Goldhaber, S. Z., Hull, R. D., Gold, A., Hernandez, A. F., Cohen, A. T., Harrington, R. A. OXFORD UNIV PRESS. 2017: 382

View details for Web of Science ID 000440509301432